Relief Therapeutics Holding AG (RLFTF)

[Toohie]

Truth is it’s very uncertain, all I can say for sure is that Aviptadil works for Covid Pneumonia and once available generally it will make us some good money. Vaccinations appear effective and it does seem like those who get reinfected are anomalies who likely have weakened immune systems. Hence, that is the risk. I do think Aviptadil will eventually get approved for ARDS due to any cause. However we do not have the data for that to be betting the house on it.